What is the HRTX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Heron Therapeutics, Inc. (HRTX) price will be around $0.43 in the next 2 weeks. This means it will increase by 29.19402985074627 from the last closing price. This prediction may vary from other time period filters for HRTX stock.

What can be the highest Possible price of HRTX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, HRTX can achieve the highest price of $0.46 which is 37.870464090809726 higher than last closing price. This prediction may vary from other time period filters for HRTX stock.

What can be the lowest Possible price of HRTX stock in next 2 weeks?

As per the forecast and algorithmic analysis, HRTX stock price can be as low as $0.40 which is 20.18524138181584 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for HRTX stock.

Will HRTX stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that HRTX stock will gain29.19402985074627 in the next 2 weeks. This prediction may vary from other time period filters for HRTX stock.

What is HRTX stock last closing price?

Last closing price of HRTX stock was $0.34.

What is HRTX stock price prediction?

HRTX stock price prediction means predicting the future closing prices of HRTX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of HRTX stock in a certain time period.

How we predict HRTX stock future prices?

If you are searching for HRTX stock forecast, analysis or price prediction, then you might be wondering what Heron Therapeutics, Inc. (HRTX) will do in the future. Our HRTX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This HRTX price prediction will likely answer most of your questions.

How frequent we update HRTX stock predictions?

We are updating the forecasts for the HRTX stock on daily basis.

Is using ML forecasting for HRTX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for HRTX stock same for all the time periods?

No, the prediction for HRTX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Heron Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.34-31.06%Since 2 Weeks

Predicted Price$0.4329.19%For 2 Weeks

Upper Predicted Price$0.4637.87%For 2 Weeks

Lower Predicted Price$0.4020.19%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of HRTX will rise by +29.19% over the next 2 Weeks and hit $0.43 by Monday, August 24, 2026. In that time frame, HRTX's share price is expected to range between $0.40 and $0.46.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 24, 2026	0.40	0.43	0.46
Aug 21, 2026	0.42	0.45	0.48
Aug 20, 2026	0.41	0.44	0.47
Aug 19, 2026	0.40	0.44	0.46
Aug 18, 2026	0.40	0.43	0.46
Aug 17, 2026	0.39	0.42	0.45
Aug 14, 2026	0.40	0.43	0.46
Aug 13, 2026	0.39	0.42	0.45
Aug 12, 2026	0.39	0.42	0.45
Aug 11, 2026	0.39	0.42	0.44

HRTX shares fell -31.74% in Monday, August 10, 2026's trading session, dropping from a previous close of $0.49 to move at $0.34. The stock demonstrated notable intraday movement (see HRTX's key stats for a full breakdown), fluctuating between $0.32 and $0.42, a +28.62% trading range. While recent weeks have seen some volatility, HRTX has managed to secure a -31.06% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 11.64M shares changing hands, 9.54M more than the previous session. This amounted to $3.90M in total market activity.

Will HRTX Continue Its Upward Trend?

According to analyst ratings and projections for HRTX, Heron Therapeutics, Inc. shares are anticipated to increase by +27.47%, potentially reaching $0.46 per share by August 24, 2026. Short-term technical indicators currently suggest a bullish sentiment for HRTX. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the HRTX stock forecast, now is a good time to buy HRTX stock because its current trading price is -22.60% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on HRTX covering social and institutional perspectives.

HRTX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into HRTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 16.67% to 29.43%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.84%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.94%, maintains a neutral outlook for the long term. Insights into HRTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Heron Therapeutics Short-Term Forecasts

HRTX Forecast For Next 5 Days

Our algorithm anticipates Heron Therapeutics (HRTX) stock could hit $0.50 by Aug 17, 2026. This represents a +49.28% fall from today's price, following a -4.70% change over the past five days.

HRTX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Heron Therapeutics, Inc. (HRTX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.46, which would mean a +37.31% increase from the current price of $0.34. Projections for this period range from a high of $0.71 to a low of $0.18.

HRTX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Heron Therapeutics's price over the next three months point to a rise. HRTX stock is expected to peak at $2.40 on Aug 11, 2026 before potentially dipping to $0.72 on Nov 10, 2026. On average, HRTX is likely to trade around $1.34 in the coming 90 days.

Heron Therapeutics Stock Forecast 2025

Based on our predictive models, Heron Therapeutics (HRTX) is expected to trade between $0.50 and $2.40 throughout 2026. This would result in an average price of $1.11, potentially offering investors a +231.34% return from current levels.

Heron Therapeutics, Inc. Monthly Forecast 2026–2027

August 2026

According to our latest forecast models, Heron Therapeutics, Inc. (HRTX) is positioned to show a strong performance in August 2026. The price is predicted to move between $1.53 and $2.40, settling at an average of $1.93. This could translate to a +476.12% gain.

September 2026

Based on current market signals, Heron Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $1.23 to $1.65, with a likely average price of $1.39. Investors could expect a potential return of +314.93%.

October 2026

Our predictive algorithms indicate Heron Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $0.79–$1.39, with an average target of $1.06. This represents a positive outlook and a possible gain of +216.42%.

November 2026

Analyzing established trends, Heron Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $0.62 and $1.00, averaging around $0.78. This suggests a +132.84% gain from current levels.

December 2026

Market indicators suggest Heron Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.50 to $0.80, with a midpoint forecast of $0.67. The stock might deliver a +100.00% gain.

January 2027

Forecasting for January 2027, models estimate that Heron Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.35 and $0.68, averaging $0.51. This signals a positive trajectory with potential returns around +52.24%.

February 2027

According to our latest forecast models, Heron Therapeutics, Inc. (HRTX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.27 and $0.52, settling at an average of $0.43. This could translate to a +28.36% gain.

March 2027

Based on current market signals, Heron Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $0.19 to $0.50, with a likely average price of $0.39. Investors could expect a potential return of +16.42%.

April 2027

Our predictive algorithms indicate Heron Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $0.10–$0.38, with an average target of $0.29. This represents a cautious outlook and a possible loss of -13.43%.

May 2027

Analyzing established trends, Heron Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $0.04 and $0.29, averaging around $0.24. This suggests a -28.36% loss from current levels.

June 2027

Market indicators suggest Heron Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $0.23, with a midpoint forecast of $0.18. The stock might deliver a -46.27% loss.

July 2027

Forecasting for July 2027, models estimate that Heron Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.16, averaging $0.13. This signals a cautious trajectory with potential returns around -61.19%.

August 2027

According to our latest forecast models, Heron Therapeutics, Inc. (HRTX) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.13, settling at an average of $0.10. This could translate to a -70.15% loss.

HRTX's history of dividends and stock splits also plays a role in long-term investor confidence.